Morepen Laboratories Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹484.16 crore, reflecting a quarter-on-quarter *(QoQ) increase of 17.63 per cent from ₹411.58 crore. This corresponds to a year-on-year *(YoY) growth of 6.93 per cent.
Operating Profit
Operating Profit stands at ₹46.32 crore, reflecting a quarter-on-quarter *(QoQ) increase of 50.88 per cent from ₹30.70 crore. This corresponds to a year-on-year *(YoY) growth of 28.17 per cent.
PBDT
PBDT stands at ₹45.81 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 19.59 per cent from ₹56.97 crore. This corresponds to a year-on-year *(YoY) growth of 14.13 per cent.
Profit Before Tax
Profit Before Tax stands at ₹35.43 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 22.46 per cent from ₹45.69 crore. This corresponds to a year-on-year *(YoY) growth of 0.62 per cent.
Net Profit
Net Profit stands at ₹27.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 32.99 per cent from ₹41.04 crore. This represents a 3.03 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Morepen Laboratories Ltd News
Morepen Laboratories Ltd Earnings
- YOY
- QOQ
Morepen Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Morepen Laboratories Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Morepen Laboratories Ltd Financial Reports
Morepen Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Morepen Labs. | 0.09% | 4.23% | 0.94% | -5.05% | -0.12% | -35.27% |
| Dishman Carbogen | -0.78% | 11.47% | 19.90% | 15.22% | -9.80% | -17.01% |
| Bliss GVS Pharma | 0.75% | 3.66% | 10.49% | 32.07% | 75.26% | 135.09% |
| Panacea Biotec | 0.20% | 4.08% | 18.93% | 24.74% | 21.75% | -19.78% |
| Kwality Pharma | 0.35% | 14.31% | 24.53% | 48.52% | 133.40% | 121.86% |
| Sai Parenteral's | 0.26% | 0.58% | 0.11% | 18.60% | 18.60% | 18.60% |
| Solara Active | -1.71% | -0.68% | 11.64% | 18.10% | 6.81% | 16.95% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : Sushil Suri
WTD & Executive Director : Sanjay Suri
Independent Non Exe. Director : Praveen Kumar Dutt
Independent Non Exe. Director : Ranjit Khattar
Independent Non Exe. Director : Savita
Independent Non Exe. Director : Sharad Jain
Company Secretary : Vipul Kumar Srivastava